These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 17659204

  • 1. Role of Rac1 GTPase activation in atrial fibrillation.
    Adam O, Frost G, Custodis F, Sussman MA, Schäfers HJ, Böhm M, Laufs U.
    J Am Coll Cardiol; 2007 Jul 24; 50(4):359-67. PubMed ID: 17659204
    [Abstract] [Full Text] [Related]

  • 2. Rac1-induced connective tissue growth factor regulates connexin 43 and N-cadherin expression in atrial fibrillation.
    Adam O, Lavall D, Theobald K, Hohl M, Grube M, Ameling S, Sussman MA, Rosenkranz S, Kroemer HK, Schäfers HJ, Böhm M, Laufs U.
    J Am Coll Cardiol; 2010 Feb 02; 55(5):469-80. PubMed ID: 20117462
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cardiac Rac1 overexpression in mice creates a substrate for atrial arrhythmias characterized by structural remodelling.
    Reil JC, Hohl M, Oberhofer M, Kazakov A, Kaestner L, Mueller P, Adam O, Maack C, Lipp P, Mewis C, Allessie M, Laufs U, Böhm M, Neuberger HR.
    Cardiovasc Res; 2010 Aug 01; 87(3):485-93. PubMed ID: 20211865
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Rosuvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, decreases cardiac oxidative stress and remodeling in Ren2 transgenic rats.
    Habibi J, Whaley-Connell A, Qazi MA, Hayden MR, Cooper SA, Tramontano A, Thyfault J, Stump C, Ferrario C, Muniyappa R, Sowers JR.
    Endocrinology; 2007 May 01; 148(5):2181-8. PubMed ID: 17317778
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Angiotensin II activates signal transducers and activators of transcription 3 via Rac1 in the atrial tissue in permanent atrial fibrillation patients with rheumatic heart disease.
    Xue XD, Huang JH, Wang HS.
    Cell Biochem Biophys; 2015 Jan 01; 71(1):205-13. PubMed ID: 25151145
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Rac1-mediated effects of HMG-CoA reductase inhibitors (statins) in cardiovascular disease.
    Adam O, Laufs U.
    Antioxid Redox Signal; 2014 Mar 10; 20(8):1238-50. PubMed ID: 23919665
    [Abstract] [Full Text] [Related]

  • 13. Nicotinamide adenine dinucleotide phosphate oxidase 4 mediates the differential responsiveness of atrial versus ventricular fibroblasts to transforming growth factor-β.
    Yeh YH, Kuo CT, Chang GJ, Qi XY, Nattel S, Chen WJ.
    Circ Arrhythm Electrophysiol; 2013 Aug 10; 6(4):790-8. PubMed ID: 23884197
    [Abstract] [Full Text] [Related]

  • 14. Mechanisms with clinical implications for atrial fibrillation-associated remodeling: cathepsin K expression, regulation, and therapeutic target and biomarker.
    Fujita M, Cheng XW, Inden Y, Shimano M, Yoshida N, Inoue A, Yamamoto T, Takeshita K, Kyo S, Taguchi N, Shi GP, Kuzuya M, Okumura K, Murohara T.
    J Am Heart Assoc; 2013 Dec 16; 2(6):e000503. PubMed ID: 24342995
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials.
    Abdul-Rahim AH, Perez AC, Fulton RL, Jhund PS, Latini R, Tognoni G, Wikstrand J, Kjekshus J, Lip GY, Maggioni AP, Tavazzi L, Lees KR, McMurray JJ, Investigators of the Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA), GISSI-Heart Failure (GISSI-HF) Committees and Investigators.
    Circulation; 2015 Apr 28; 131(17):1486-94; discussion 1494. PubMed ID: 25810334
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Inhibition of aldosterone synthase (CYP11B2) by torasemide prevents atrial fibrosis and atrial fibrillation in mice.
    Adam O, Zimmer C, Hanke N, Hartmann RW, Klemmer B, Böhm M, Laufs U.
    J Mol Cell Cardiol; 2015 Aug 28; 85():140-50. PubMed ID: 26047574
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.